Blood pressure, breathing, and the carotid body

Lancet

Volumn 354, Issue 9183, 1999, Pages 969-970

  Calverley, P M A ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; BREATHING PATTERN; CARDIOVASCULAR DISEASE; CAROTID BODY; CAROTID BODY CHEMORECEPTOR; CLINICAL ARTICLE; CONTROLLED STUDY; HEART RATE; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SLEEP APNEA SYNDROME;

EID: 0033581421     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90135-6     Document Type: Note

References (16)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 328:1993;1230-1235.
2. Douglas N.J., Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet. 344:1994;653-655.
3. Wright J., Johns R., Watt I., Melville A., Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ. 314:1997;851-860.
4. Young T., Peppard P., Palta M.et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 157:1997;1746-1752.
5. Engleman H.M., Gough K., Martin S.E., Kingshott R.N., Padfield P.L., Douglas N.J. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers" Sleep. 19:1996;378-381.
6. Rees K., Spence D.P., Earis J.E., Calverley P.M. Arousal responses from apneic events during non-rapid-eye-movement sleep. Am J Respir Crit Care Med. 152:1995;1016-1021.
7. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 96:1995;1897-1904.
8. Leuenberger U., Jacob E., Sweer L., Waravdekar N., Zwillich C., Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol. 79:1995;581-588.
9. Narkiewicz K., Somers V.K. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens. 15:1997;1613-1619.
10. Narkiewicz K., van de Borne P.J., Cooley R.L., Dyken M.E., Somers V.K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 98:1998;772-776.
11. Hedner J., Darpo B., Ejnell H., Carlson J., Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 8:1995;222-229.
12. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest. 99:1997;106-109.
13. Narkiewicz K., van de Borne P.J., Montano N., Dyken M.E., Phillips B.G., Somers V.K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation. 97:1998;943-945.
14. Narkiewicz K., Montano N., Cogliati C., van de Borne P.J., Dyken M.E., Somers V.K. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 98:1998;1071-1077.
15. Narkiewicz K., van de Borne P.J., Pesek C.A., Dyken M.E., Montano N., Somers V.K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 99:1999;1183-1189.
16. Osanai S., Akiba Y., Fujiuchi S.et al. Depression of peripheral chemosensitivity by a dopaminergic mechanism in patients with obstructive sleep apnoea syndrome. Eur Respir J. 13:1999;418-423.